Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment

Journal of Clinical Virology

Volumn 50, Issue 3, 2011, Pages 212-216

  Mackay, Helen J ^a   McGee, Jacob ^a   Villa, Diego ^a   Gubbay, Jonathan B ^b   Tinker, Lisa M ^a   Shi, Lily ^b   Kuruvilla, John ^a   Wang, Lisa ^a   MacAlpine, Katrina ^a   Oza, Amit M ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

Author keywords

Cytotoxic chemotherapy; Hematological malignancy; PH1N1 vaccination; Solid tumor

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; CYCLOPHOSPHAMIDE; DOXORUBICIN; INFLUENZA VACCINE; PREDNISONE; RITUXIMAB; VINCRISTINE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD CELL COUNT; BLOOD SAMPLING; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG SAFETY; ESOPHAGUS CANCER; FATIGUE; FEMALE; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; IMMUNOGENICITY; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; LEUKOCYTE COUNT; MALE; MYELOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; SEROCONVERSION; SOLID TUMOR; T CELL LYMPHOMA; UTERUS CANCER;

ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES;

EID: 79851512197     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.11.013     Document Type: Article

References (28)

1. Yousuf H.M., Englund J., Couch R., Roston K., Luna M., Goodrich J., et al. Influenza among hospitalized adults with leukemia. Clin Infect Dis 1997, 24:1095-1991.
2. Schepetiuk S., Papanaoum K., Qiao M. Spread of influenza A virus infection in hospitalised patients with cancer. Aust N Z J Med 1998, 28:47-76.
3. Whimbey E., Elting L.S., Couch R.B., Low E., Williams L., Champlin R.E. Influenza A virus infections among bone marrow transplant recipients. Bone Marrow Transplant 1994, 13:437-440.
4. Centers for Disease Control and Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices ACIP. MMWR 2009, 58:1-52. http://www.cdc.gov/mmwr/preview.
5. Brydak L.B., Guzy J., Starzyk J., Machala M., Gozdz S.S. Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer 2000, 9:65-68.
6. Shildt R.A., Luedke D.W., Kasai G., El-Beheri S., Laham M.N. Antibody response to influenza immunization in adult patients with malignant disease. Cancer 1979, 44:1629-1635.
7. Nordoy T., Aaberge I.S., Husebelkk A., Samdell H., Steinert S., Melby H. Cancer patients undergoing chemotherapy show serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol 2002, 19:71-78.
8. Anderson H., Petrie K., Berrisford C., Charlett A., Thatcher N., Zambon M. Seroconversion in patients with lung cancer. Br J Cancer 1999, 80:219-220.
9. Ganz P.A., Shanley J.D., Cherry J.D. Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer 1978, 42:2244-2247.
10. Pollyea D.A., Brown J.M.Y., Horning S.J. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010, 28:2481-2490.
11. Loulergue P., Mir O., Alexandre J., Ropert S., Goldausser J., Launay O., et al. Low influenza vaccination among patients receiving chemotherapy for cancer. Ann Oncol 2008, 19:1658.
12. Earle C.C. Influenza vaccination in elderly patients with advanced colorectal cancer. J Clin Oncol 2003, 21:1161-1166.
13. Yee S.S., Dutta P.R., Solin L.J., Vapiwala N., Kao G.D. Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy. J Support Oncol 2010, 8:28-34.
14. CDC Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:467-470.
15. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459:1122-1125.
16. Greenberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittelson C., Bennett J., et al. Response after one dose of a monovalent influenza A (H1N1) 2009 Vaccine - preliminary report. N Engl J Med 2009, 10(September).
17. Clark T.W., Pareek M., Hoschler K., Dillon H., Nicholson K.G., Groth N., et al. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine - preliminary report. N Engl J Med 2009, 10(September).
18. World Health Organization WHO manual on animal influenza diagnosis and surveillance 2002.
19. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Br Med Bull 1979, 35:69-75.
20. EMEA Guideline on influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context 2007, European Medicines Evaluation Agency, Committee for Human Medicinal Products, London, [Report No.: EMEA/CHMP/VWP/263499/2006 Contract No.: Document Number].
21. Plennevaux E., Sheldon E., Blatter M., Reeves-Hoche M.K., Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010, 375:41-48.
22. Gribabis D.A., Panayiotidis P., Boussiotis V.A., Hannoun C., Pangalis G.A. Influenza virus vaccine in B-cell chronic lympho-cytic leukaemia patients. Acta Haematol 1994, 91:115-118.
23. Mazza J.J., Yale S.H., Arrowood J.R., Roston K., Luna M., Goodrich J., et al. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res 2005, 3:214-220.
24. Ljungman P., Nahi H., Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 2005, 130:96-98.
25. Brydak L.B., Machala M., Centkowski P., Warzocha K., Bilinski P. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine 2006, 24(44-46):6620-6623.
26. Van der Kolk L.E., Baars J.W., Prins M.H., Van Oers M.H. Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 2002, 100:2257-2259.
27. Hobson D., Curry R.L., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972, 70:767-777.
28. Ortbals D.W., Liebhaber H., Presant C.A., Van Amburg A.L., Lee J.Y. Influenza immunization of adult patients with malignant diseases. Ann Intern Med 1977, 87:552-557.